---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-127475"
form_type: "8-K"
ticker: "HEPA"
cik: "0001583771"
company_name: "Hepion Pharmaceuticals, Inc."
filed_at: "2022-12-16T23:59:59+00:00"
generated_at: "2026-06-21T03:20:31.712587+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Hepion shareholders approve reverse stock split; Board to set ratio 1:2 to 1:20

## Summary
- Special meeting held Dec 15, 2022; proposal to amend charter for reverse split approved.
- Vote: 6,757,528,739 for, 3,262,017,173 against, 38,856,945 abstained; 0 broker non-votes.
- Board authorized to select ratio between 1:2 and 1:20 within one year of meeting.
- Proposal covers all outstanding common and preferred shares as of Nov 8, 2022 record date.

## SEC filing metadata
- accession: 0001104659-22-127475
- form_type: 8-K
- ticker: HEPA
- cik: 0001583771
- company_name: Hepion Pharmaceuticals, Inc.
- filed_at: 2022-12-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1583771/000110465922127475/0001104659-22-127475-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1583771/000110465922127475/tm2232810d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-127475
- JSON: https://secwatch.observer/filing/0001104659-22-127475.json
- Plain text: https://secwatch.observer/filing/0001104659-22-127475.txt

## Key facts
- Shareholder Votes
  Hepion Pharmaceuticals, Inc. shareholders approved Adoption and approval of an amendment to the Certificate of Incorporation to effect a reverse stock split of common stock at a ratio ranging from 1:2 to 1:20, with the exact ratio determined by the Board at the 2022-12-15 meeting.
  - Proposal: reverse split
  - Outcome: passed
  - Meeting: 2022-12-15
  source text: The proposal to adopt and approve an amendment to the Charter to effect a reverse stock split of the Company’s issued and outstanding shares of Common Stock, at a specific ratio, ranging from one-for-two (1:2) to one-for-twenty (1:20), at any time prior to the one-year anniversary date of the Special Meeting, with the exact ratio to be determined by the Board was approved by a majority of the voting power of the outstanding shares of Common Stock, Series A Preferred Stock Series F Preferred Stock and Series G Preferred Stock entitled to vote on the proposal, based upon the following votes: Votes For Votes Against Votes Abstained Broker Non-Vote 6,757,528,739 3,262,017,173 38,856,945 0
  evidence_url: https://www.sec.gov/Archives/edgar/data/1583771/000110465922127475/0001104659-22-127475-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.